From Financial Modeling Prep: 2024-12-18 00:00:03

In summary, Applied DNA Sciences, Inc. reported an improved earnings per share of -$0.32, better than the estimated -$0.33. However, revenue fell short at $813,106 compared to the expected $899,000, signaling challenges in meeting revenue targets. With a price-to-sales ratio of 3.47 and a debt-to-equity ratio of 0.07, APDN shows conservative debt use and strong liquidity.



Read more at Financial Modeling Prep:: Applied DNA Sciences, Inc. (NASDAQ:APDN) Earnings …